EP 3197487 A1 20170802 - VACCINATION OF IMMUNOCOMPROMISED SUBJECTS
Title (en)
VACCINATION OF IMMUNOCOMPROMISED SUBJECTS
Title (de)
IMPFUNG IMMUNGESCHWÄCHTER PERSONEN
Title (fr)
VACCINATION DE SUJETS IMMUNODÉPRIMÉS
Publication
Application
Priority
- US 201462056019 P 20140926
- EP 14192174 A 20141106
- US 201562149351 P 20150417
- IB 2015057388 W 20150925
Abstract (en)
[origin: WO2016046799A1] Disclosed herein are methods for enhancing immune responses to a vaccine in immunocompromised individuals, including those receiving a statin therapy. Related products are also provided.
IPC 8 full level
A61K 39/145 (2006.01); A61K 39/39 (2006.01)
CPC (source: EP KR US)
A61K 39/12 (2013.01 - EP KR US); A61K 39/145 (2013.01 - EP KR US); A61K 39/39 (2013.01 - EP KR US); A61P 31/12 (2017.12 - EP); A61P 31/16 (2017.12 - EP); A61P 37/04 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C12N 7/00 (2013.01 - US); A61K 2039/545 (2013.01 - EP KR US); A61K 2039/55566 (2013.01 - EP KR US); C12N 2760/16134 (2013.01 - EP KR US); C12N 2760/16234 (2013.01 - EP KR US)
Citation (search report)
See references of WO 2016046799A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2016046799 A1 20160331; AU 2015323334 A1 20170413; AU 2015323334 B2 20210225; AU 2021202331 A1 20210513; CA 2962214 A1 20160331; EP 3197487 A1 20170802; EP 3197487 B1 20220803; JP 2017528511 A 20170928; JP 2020073547 A 20200514; KR 20170063750 A 20170608; US 10716844 B2 20200721; US 11406701 B2 20220809; US 2017304429 A1 20171026; US 2020147203 A1 20200514; US 2020306365 A1 20201001
DOCDB simple family (application)
IB 2015057388 W 20150925; AU 2015323334 A 20150925; AU 2021202331 A 20210419; CA 2962214 A 20150925; EP 15781436 A 20150925; JP 2017516959 A 20150925; JP 2019238370 A 20191227; KR 20177010639 A 20150925; US 201515514154 A 20150925; US 202016739358 A 20200110; US 202016901185 A 20200615